SEC Comment Letter for Zomedica Corp. (ZOM) (CIK 0001684144) (ZOMDF) — Oct 14, 2020
Zomedica Corp. (ZOM) (CIK 0001684144)
Date: Oct. 14, 2020 · CIK: 0001684144 · Accession: 0000000000-20-009687
AI Filing Summary & Sentiment
File numbers found in text: 333-249401
Letter
United States securities and exchange commission logo October 14, 2020 Robert Cohen Interim Chief Executive Officer Zomedica Corp. 100 Phoenix Drive, Suite 180 Ann Arbor, MI 48108 Re:Zomedica Corp. Registration Statement on Form S-4 Filed October 9, 2020 File No. 333-249401 Dear Mr. Cohen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: John D. Hogoboom, Esq.
Show Raw Text
United States securities and exchange commission logo
October 14, 2020
Robert Cohen
Interim Chief Executive Officer
Zomedica Corp.
100 Phoenix Drive, Suite 180
Ann Arbor, MI 48108
Re:Zomedica Corp.
Registration Statement on Form S-4
Filed October 9, 2020
File No. 333-249401
Dear Mr. Cohen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: John D. Hogoboom, Esq.